期刊文献+

肝硬化患者并发感染相关性胆汁淤积症54例临床特点及转归 被引量:3

The clinical features and prognosis of sepsis-associated cholestasis in patients with liver cirrhosis
暂未订购
导出
摘要 目的加强对肝硬化患者并发感染相关性胆汁淤积症的认识,分析肝硬化患者并发感染相关性胆汁淤积症的临床特点、危险因素及转归。方法回顾性分析肝硬化患者并发感染相关性胆汁淤积症的临床资料,分析其临床特征及其预后,比较54例肝硬化患者并发感染相关性胆汁淤积症与同期住院的发生感染但未出现胆汁淤积症(对照组)126例肝硬化患者在年龄、性别、Child-Pugh分级、早期及时经验性抗菌药物应用的差异。结果 54例肝硬化患者并发感染相关性胆汁淤积症的感染部位:腹腔感染(自发性细菌性腹膜炎,SBP)20例、尿路感染18例、胆道感染6例、肠道感染4例、肺部感染4例、部位不明确2例,根据Child-Pugh分级约有55.56%的患者为Child C级。两组比较,年龄、Child-Pugh分级、早期及时经验性应用抗菌药物等,差异均有统计学意义(P<0.05);观察组中病死率15.00%,高于对照组的4.36%,差异有统计学意义(P<0.05)。结论肝硬化患者并发感染相关性胆汁淤积症对预后有不良影响,尤其合并有肝肾综合征者病死率较高,应高度重视临床及实验诊断,针对其临床特征实施相应措施。 Objective To explore the clinical features and prognosis of cirrhotic patients with concomitant sepsis-associated cholestasis.Methods A retrospective analysis of 180 patients with liver cirrhosis was performed.The clinical data,including infection,age,sex,Child-Pugh classification and antibiotic treatment,were compared between the patients with sepsis-associated cholestasis and those without using the Chi-squared test.Results Sepsis-associated cholestasis occurred in 30%(n=54) of the liver cirrhosis patients.The sepsis-related infections included spontaneous bacterial peritonitis(n=20),urinary tract infection(n=18),biliary tract infection(n=6),intestinal infection(n=4),pulmonary infection(n=4),and undetermined infection(n=2).The sepsis-associated cholestasis group showed significantly older age,higher Child-Pugh score,and increased antibiotics(all,P0.05).The mortality rate was significantly higher in the sepsis-associated cholestasis group(16/54 vs.13/126 in the non-septic cholestasis group,P0.05).Conclusion Sepsis-associated cholestasis in patients with advanced cirrhosis is associated with a poor prognosis.
出处 《临床肝胆病杂志》 CAS 2013年第3期208-210,共3页 Journal of Clinical Hepatology
关键词 胆汁淤积 肝硬化 细菌感染 cholestasis liver cirrhosis bacterial infections
  • 相关文献

参考文献12

  • 1中华医学会传染病与,寄生虫病学分会,肝病学分会.病毒性肝炎防治方案[J].中华肝脏病杂志,2000,8(6):324-329. 被引量:14017
  • 2Fuchs M, Sanval AJ. Sepsis and cholestasis [ J]. Clin LiverDis, 2008, 12(1 ) : 151 -172.
  • 3樊和斌,陈安慎,严福明,马燕妮,朱幼芙,杨东亮.感染相关性胆汁淤积症35例临床分析[J].胃肠病学和肝病学杂志,2010,19(4):367-368. 被引量:3
  • 4Khalil S,Shah D, Faridi MM, et al. Prevalence and outcomeof hepatobiliary dysfunction in neonatal septicaemia [ J ] JPediatr Gastroenterol Nutr, 2012, 54(2) ; 218 -222.
  • 5Watanakunakorn C, Chan SJ, Demarco DG, et al. Staphylo-coccus aureus bacteremia : significance of hyperbilirubinemia[J]. Scand J Infect Dis, 1987,19(2) : 195 -203.
  • 6Famularo G, De Simone C, Nicotra GC. Jaundice and the sepsissyndrome: a neglected link[J]. Eue J Intern Med, 2003, 14(4): 269 -271.
  • 7Schuppan D, Afdhal NH. Liver cirrhosis[ J]. Lancet, 2008,371(9615) : 838 -851.
  • 8Kalambokis GN, Tsianos EV. Rifaximin reduces endotoxemiaand improves liver function and disease severity in patientswith decompensated cirrhosis [ J ]. Hepatology, 2012, 55(2): 655 -656.
  • 9Benjamin J, Singla V, Arora I, et al. Intestinal permeabilityand complications in liver cirrhosis: A prospective cohortstudy[ J]. Hepatol Res, 2012,may 25.
  • 10陆伦根.胆汁的分泌、排泄和调节及胆汁淤积发生机制[J].临床肝胆病杂志,2011,27(6):570-571. 被引量:15

二级参考文献18

  • 1Bazlul Karim AS, Kamal M. Cholestatic jaundice during infancy: experience at a tertiary-care center in Bangladesh [ J]. Indian J Gastroenterol, 2005, 24(2) : 52-54.
  • 2Naudi AB, Ammari AB, Fung DE. A report of 2 cases of green pigmentation in the primary dentition associated with cholestasis caused by sepsis [J]. J Dent Child (Chic), 2008, 75(1): 91-94.
  • 3Fuchs M, Sanyal AJ. Sepsis and cholestasis [ J ]. Clin Liver Dis, 2008, 12( 1 ) : 151-172.
  • 4Giovannini I, Chiarla C, Giuliante F, et al. Sepsis-induced cholestasis [J]. Hepatology, 2008, 47(1): 361.
  • 5Angus DC, Linde Zwirble WT, Lidicker J, et al. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care [J].Crit 2:are Med, 2001, 29 (7): 1303-1310.
  • 6Miyaji T, Hu X, Yuen PS, et al. Ethyl pyruvate decreases sepsis-induced acute renal failure and multiple organ damage in aged mice [J]. Kidney Int, 2003, 64 (5): 1620-1631.
  • 7Jelkmann W, Wagner K. Beneficial and ominous aspects of the pleiotropic action of erythropoietin [J]. Ann Hematol, 2004, 83 (11): 673-686.
  • 8Patel NS, Sharpies EJ, Cuzzocrea S, et al. Pretreatment with EPO reduces the injury and dysfunction caused by ischemia/reperfusion in the mouse kidney in vivo [J].KidneyInt, 2004, 66 (3): 983-989.
  • 9Li XJ, Wang XW, Du YJ. Protective effects of erythropoietin on myocardial infarction in rats: the role of AMP-activated protein kinase signaling pathway[J].Am J Med Sci, 2011, 342 (2): 153- 159.
  • 10Calapai G, Marciano MC, Coriea F, et al. Erythropoietin protects against brain ischemic injury by inhibition of nitric oxide formation [J].Eur J Pharmacol, 2000, 401 (3) : 349-356.

共引文献14033

同被引文献23

引证文献3

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部